Related Experiment Video
Updated: May 19, 2026

Phenotypic Analysis and Isolation of Murine Hematopoietic Stem Cells and Lineage-committed Progenitors
Published on: July 8, 2012
Hematopoietic Progenitor Cell Apheresis processing
Eleanor S Hamilton1, Edmund K Waller
1Cellular Therapies Laboratory, Emory University Hospital, Atlanta, GA, USA. Ellie.hamilton@emoryhealthcare.org
Modern apheresis generally results in a mononuclear cell product that is highly enriched for hematopoietic stem and progenitor cells when performed on patients who have mobilized with myeloid growth factors, CXCR4 antagonists or upon recovery from cytotoxic chemotherapy. The duration of apheresis during the days in which elevated numbers of CD34 positive cells are present in the blood depends upon the efficiency of the apheresis maneuver, the numbers of the CD34 target cell population in the blood, and the weight of the intended transplant recipient. The ability to freeze a hematopoietic progenitor cell (HPC) graft and subsequently thaw it while retaining viability of the hematopoietic stem and progenitor cell population has permitted routine collection of autologous hematopoietic progenitor cell grafts for treatment of patients with cancer using myeloablative doses of chemotherapy and radiation with stem cell support.
Modern apheresis generally results in a mononuclear cell product that is highly enriched for hematopoietic stem and progenitor cells when performed on patients who have mobilized with myeloid growth factors, CXCR4 antagonists or upon recovery from cytotoxic chemotherapy. The duration of apheresis during the days in which elevated numbers of CD34 positive cells are present in the blood depends upon the efficiency of the apheresis maneuver, the numbers of the CD34 target cell population in the blood, and the weight of the intended transplant recipient. The ability to freeze a hematopoietic progenitor cell (HPC) graft and subsequently thaw it while retaining viability of the hematopoietic stem and progenitor cell population has permitted routine collection of autologous hematopoietic progenitor cell grafts for treatment of patients with cancer using myeloablative doses of chemotherapy and radiation with stem cell support.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
14:37Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
Published on: November 1, 2017
Related Concept Videos
Hematopoiesis
Lineage Commitment
Multipotency of Hematopoietic Stem Cells
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Production of Formed Elements
Most HSCs commit to...
Regulation of Hematopoietic Stem Cells